Sfoglia per Autore
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study
2018 Jommi, Claudio; Armeni, Patrizio; Battista, Margherita; di Procolo, Paolo; Conte, Giuseppe; Ronco, Claudio; Cozzolino, Mario; Costanzo, Anna Maria; di Luzio Paparatti, Umberto; Concas, Gabriella; Remuzzi, Giuseppe
Prezzo, rimborso e accesso ai farmaci in Italia: le proposte di riforma di quattro panel di esperti
2019 Jommi, Claudio; Apolone, Giovanni; Cicchetti, Americo; Conte, Pierfranco; Fattore, Giovanni; Mantoan, Domenico; Marata, Annamaria; Schincariol, Paolo; Scroccaro, Giovanna; Tosolini, Francesca; Buzzetti, Giuliano
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol
2019 Riva, Silvia; Bryce, Jane; De Lorenzo, Francesco; Del Campo, Laura; Di Maio, Massimo; Efficace, Fabio; Frontini, Luciano; Giannarelli, Diana; Gitto, Lara; Iannelli, Elisabetta; Jommi, Claudio; Montesarchio, Vincenzo; Traclò, Francesca; Vaccaro, Concetta Maria; Gallo, Ciro; Perrone, Francesco
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
2019 Villa, Federico; Tutone, Michaela; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni; Jommi, Claudio
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals
2019 Jommi, Claudio; Cavazza, Marianna
Quanto vale la negoziazione del prezzo di un nuovo farmaco in Italia?
2020 Villa, Federico; Jommi, Claudio; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni
Implementation of value-based pricing for medicines
2020 Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Bertolani, Arianna; Otto, Monica
Patient access to oral nutritional supplements: which policies count?
2020 Cavazza, Marianna; Banks, Helen; Muscaritoli, Maurizio; Rondanelli, Mariangela; Zandonà, Emanuela; Jommi, Claudio
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service
2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco
The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service
2020 Jommi, Claudio; Cipriani, Filippo; Fanelli, Francesca; Pedone, Maria Paola; Canonica, Walter
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service
2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco
Esiti di salute e performance del Servizio Sanitario Nazionale
2021 Ardito, Vittoria; Ciani, Oriana; Federici, Carlo; Furnari, Alessandro; Finch, Aureliano; Jommi, Claudio; Malandrini, Francesco; Meregaglia, Michela; Tarricone, Rosanna
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement)
2021 Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Alberti, Chiara; Bandello, Francesco; Bordonaro, Roberto; Caprodossi, Andrea; Di Maio, Massimo; Gaudioso, Antonio; Giuliani, Giovanni; Langella, Roberto; Marata, Anna Maria; Patarnello, Francesca; Pinto, Carmine; Rasi, Guido; Villa, Federico
Variables affecting pricing of orphan drugs: the Italian case
2021 Jommi, Claudio; Listorti, Elisabetta; Villa, Federico; Ghislandi, Simone; Genazzani, Armando; Cangini, Agnese; Trotta, Francesco
Next-Generation Sequencing in clinical practice: is it a cost-saving alternative to a single-gene testing approach?
2021 Pruneri, Giancarlo; De Braud, Filippo; Sapino, Anna; Aglietta, Massimo; Vecchione, Andrea; Giusti, Raffaele; Marchio, Caterina; Scarpino, Stefania; Baggi, Anna; Bonetti, Giuseppe; Franzini, Jean Marie; Volpe, Marco; Jommi, Claudio
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system
2021 Riva, Silvia; Arenare, Laura; Di Maio, Massimo; Efficace, Fabio; Montesarchio, Vincenzo; Frontini, Luciano; Giannarelli, Diana; Bryce, Jane; Del Campo, Laura; De Lorenzo, Francesco; Iannelli, Elisabetta; Traclò, Francesca; Gitto, Lara; Jommi, Claudio; Vaccaro, Concetta Maria; Barberio, Daniela; Cinieri, Saverio; Porta, Camillo; Del Mastro, Lucia; Zagonel, Vittorina; Aligi Cogoni, Alessio; Bordonaro, Roberto; Gimigliano, Anna; Piccirillo, Maria Carmela; Guizzaro, Lorenzo; Gallo, Ciro; Perrone, Francesco
The economic impact of compassionate use of medicines
2021 Jommi, Claudio; Pantellini, Federico; Stagi, Lisa; Verykiou, Maria; Cavazza, Marianna
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system
2021 Galeone, Carlotta; Bruzzi, Paolo; Jommi, Claudio
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
2021 Ronco, Virginia; Dilecce, Myriam; Lanati, Elena; Canonico, Pier Luigi; Jommi, Claudio
Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects
2021 Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio
Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
---|---|---|---|---|
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study | 1-gen-2018 | Jommi, Claudio; Armeni, Patrizio; Battista, Margherita; di Procolo, Paolo; Conte, Giuseppe; Ronco, Claudio; Cozzolino, Mario; Costanzo, Anna Maria; di Luzio Paparatti, Umberto; Concas, Gabriella; Remuzzi, Giuseppe | PHARMACOECONOMICS-OPEN | - |
Prezzo, rimborso e accesso ai farmaci in Italia: le proposte di riforma di quattro panel di esperti | 1-gen-2019 | Jommi, Claudio; Apolone, Giovanni; Cicchetti, Americo; Conte, Pierfranco; Fattore, Giovanni; Mantoan, Domenico; Marata, Annamaria; Schincariol, Paolo; Scroccaro, Giovanna; Tosolini, Francesca; Buzzetti, Giuliano | POLITICHE SANITARIE | - |
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol | 1-gen-2019 | Riva, Silvia; Bryce, Jane; De Lorenzo, Francesco; Del Campo, Laura; Di Maio, Massimo; Efficace, Fabio; Frontini, Luciano; Giannarelli, Diana; Gitto, Lara; Iannelli, Elisabetta; Jommi, Claudio; Montesarchio, Vincenzo; Traclò, Francesca; Vaccaro, Concetta Maria; Gallo, Ciro; Perrone, Francesco | BMJ OPEN | - |
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency | 1-gen-2019 | Villa, Federico; Tutone, Michaela; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni; Jommi, Claudio | HEALTH POLICY | - |
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals | 1-gen-2019 | Jommi, Claudio; Cavazza, Marianna | GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT | - |
Quanto vale la negoziazione del prezzo di un nuovo farmaco in Italia? | 1-gen-2020 | Villa, Federico; Jommi, Claudio; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni | RECENTI PROGRESSI IN MEDICINA | - |
Implementation of value-based pricing for medicines | 1-gen-2020 | Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Bertolani, Arianna; Otto, Monica | CLINICAL THERAPEUTICS | - |
Patient access to oral nutritional supplements: which policies count? | 1-gen-2020 | Cavazza, Marianna; Banks, Helen; Muscaritoli, Maurizio; Rondanelli, Mariangela; Zandonà, Emanuela; Jommi, Claudio | NUTRITION | - |
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service | 1-gen-2020 | Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco | CLINICAL THERAPEUTICS | - |
The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service | 1-gen-2020 | Jommi, Claudio; Cipriani, Filippo; Fanelli, Francesca; Pedone, Maria Paola; Canonica, Walter | GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT | - |
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service | 1-gen-2020 | Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco | CLINICAL THERAPEUTICS | - |
Esiti di salute e performance del Servizio Sanitario Nazionale | 1-gen-2021 | Ardito, Vittoria; Ciani, Oriana; Federici, Carlo; Furnari, Alessandro; Finch, Aureliano; Jommi, Claudio; Malandrini, Francesco; Meregaglia, Michela; Tarricone, Rosanna | - | Egea |
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) | 1-gen-2021 | Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Alberti, Chiara; Bandello, Francesco; Bordonaro, Roberto; Caprodossi, Andrea; Di Maio, Massimo; Gaudioso, Antonio; Giuliani, Giovanni; Langella, Roberto; Marata, Anna Maria; Patarnello, Francesca; Pinto, Carmine; Rasi, Guido; Villa, Federico | RECENTI PROGRESSI IN MEDICINA | - |
Variables affecting pricing of orphan drugs: the Italian case | 1-gen-2021 | Jommi, Claudio; Listorti, Elisabetta; Villa, Federico; Ghislandi, Simone; Genazzani, Armando; Cangini, Agnese; Trotta, Francesco | ORPHANET JOURNAL OF RARE DISEASES | - |
Next-Generation Sequencing in clinical practice: is it a cost-saving alternative to a single-gene testing approach? | 1-gen-2021 | Pruneri, Giancarlo; De Braud, Filippo; Sapino, Anna; Aglietta, Massimo; Vecchione, Andrea; Giusti, Raffaele; Marchio, Caterina; Scarpino, Stefania; Baggi, Anna; Bonetti, Giuseppe; Franzini, Jean Marie; Volpe, Marco; Jommi, Claudio | PHARMACOECONOMICS-OPEN | - |
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system | 1-gen-2021 | Riva, Silvia; Arenare, Laura; Di Maio, Massimo; Efficace, Fabio; Montesarchio, Vincenzo; Frontini, Luciano; Giannarelli, Diana; Bryce, Jane; Del Campo, Laura; De Lorenzo, Francesco; Iannelli, Elisabetta; Traclò, Francesca; Gitto, Lara; Jommi, Claudio; Vaccaro, Concetta Maria; Barberio, Daniela; Cinieri, Saverio; Porta, Camillo; Del Mastro, Lucia; Zagonel, Vittorina; Aligi Cogoni, Alessio; Bordonaro, Roberto; Gimigliano, Anna; Piccirillo, Maria Carmela; Guizzaro, Lorenzo; Gallo, Ciro; Perrone, Francesco | BMJ OPEN | - |
The economic impact of compassionate use of medicines | 1-gen-2021 | Jommi, Claudio; Pantellini, Federico; Stagi, Lisa; Verykiou, Maria; Cavazza, Marianna | BMC HEALTH SERVICES RESEARCH | - |
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system | 1-gen-2021 | Galeone, Carlotta; Bruzzi, Paolo; Jommi, Claudio | BMJ OPEN | - |
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations? | 1-gen-2021 | Ronco, Virginia; Dilecce, Myriam; Lanati, Elena; Canonico, Pier Luigi; Jommi, Claudio | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE | - |
Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects | 1-gen-2021 | Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio | CLINICAL DRUG INVESTIGATION | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile